NMDA-independent form of long-term potentiation produced by tetraethylammonium in the hippocampal CA1 region.
Aniksztejn
L
L
INSERM U29, Hôpital de Port-Royal, Paris, France.
Ben-Ari
Y
Y
D015761:4-Aminopyridine / Q000494:pharmacology; D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D015220:Calcium Channels / Q000187:drug effects; D004357:Drug Synergism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D016202:N-Methylaspartate; D051381:Rats; D011919:Rats, Inbred Strains; D013757:Tetraethylammonium Compounds / Q000494:pharmacology*
D015220:Calcium Channels; D013757:Tetraethylammonium Compounds; D001224:Aspartic Acid; D016202:N-Methylaspartate; D015761:4-Aminopyridine